Auditory confounds can drive online effects of transcranial ultrasonic stimulation in humans.

TMS TUS auditory confound design experimental control human neuromodulation neuroscience primary motor cortex transcranial magnetic stimulation transcranial ultrasound stimulation

Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
27 Aug 2024
Historique:
medline: 27 8 2024
pubmed: 27 8 2024
entrez: 27 8 2024
Statut: epublish

Résumé

Transcranial ultrasonic stimulation (TUS) is rapidly emerging as a promising non-invasive neuromodulation technique. TUS is already well-established in animal models, providing foundations to now optimize neuromodulatory efficacy for human applications. Across multiple studies, one promising protocol, pulsed at 1000 Hz, has consistently resulted in motor cortical inhibition in humans (Fomenko et al., 2020). At the same time, a parallel research line has highlighted the potentially confounding influence of peripheral auditory stimulation arising from TUS pulsing at audible frequencies. In this study, we disentangle direct neuromodulatory and indirect auditory contributions to motor inhibitory effects of TUS. To this end, we include tightly matched control conditions across four experiments, one preregistered, conducted independently at three institutions. We employed a combined transcranial ultrasonic and magnetic stimulation paradigm, where TMS-elicited motor-evoked potentials (MEPs) served as an index of corticospinal excitability. First, we replicated motor inhibitory effects of TUS but showed through both tight controls and manipulation of stimulation intensity, duration, and auditory masking conditions that this inhibition was driven by peripheral auditory stimulation, not direct neuromodulation. Furthermore, we consider neuromodulation beyond driving overall excitation/inhibition and show preliminary evidence of how TUS might interact with ongoing neural dynamics instead. Primarily, this study highlights the substantial shortcomings in accounting for the auditory confound in prior TUS-TMS work where only a flip-over sham and no active control was used. The field must critically reevaluate previous findings given the demonstrated impact of peripheral confounds. Furthermore, rigorous experimental design via (in)active control conditions is required to make substantiated claims in future TUS studies. Only when direct effects are disentangled from those driven by peripheral confounds can TUS fully realize its potential for research and clinical applications.

Identifiants

pubmed: 39190585
doi: 10.7554/eLife.88762
pii: 88762
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Nederlandse Organisatie voor Wetenschappelijk Onderzoek
ID : 18919
Organisme : Nederlandse Organisatie voor Wetenschappelijk Onderzoek
ID : 452-17-016
Organisme : Holland High Tech
ID : HiTMaT-38H3
Organisme : CIHR
ID : FDN 154292
Pays : Canada
Organisme : CIHR
ID : ENG 173742
Pays : Canada
Organisme : Natural Sciences and Engineering Research Council of Canada
ID : RGPIN-2020-04176
Organisme : Natural Sciences and Engineering Research Council of Canada
ID : RTI-2020-0024

Informations de copyright

© 2023, Kop et al.

Déclaration de conflit d'intérêts

BK, YS, TG, TN, JL, SM, SF, ME, MH, MN, AR, GD, AC, TB, RC No competing interests declared, UH is the head of software development at sync2brain GmbH, where the bossdevice used in Experiment IV was developed, Hd, LV Reviewing editor, eLife

Références

Nat Neurosci. 2018 Feb;21(2):174-187
pubmed: 29311747
Brain Stimul. 2022 Jan-Feb;15(1):109-115
pubmed: 34826626
Brain Stimul. 2022 May-Jun;15(3):769-779
pubmed: 35561960
J Mem Lang. 2013 Apr;68(3):
pubmed: 24403724
Psychophysiology. 2007 Jul;44(4):522-9
pubmed: 17565658
Curr Opin Neurobiol. 2018 Jun;50:222-231
pubmed: 29674264
Ann Neurol. 2022 Feb;91(2):238-252
pubmed: 34964172
J Neurosci. 2016 May 11;36(19):5289-98
pubmed: 27170126
Sci Rep. 2022 Feb 9;12(1):2182
pubmed: 35140238
Neuroimage. 2021 Nov;243:118557
pubmed: 34487826
J Neurosci. 2013 Mar 6;33(10):4550-60
pubmed: 23467371
PLoS One. 2008;3(10):e3511
pubmed: 18958151
Sci Rep. 2018 Jul 3;8(1):10007
pubmed: 29968768
J Cogn Neurosci. 2021 Feb;33(2):195-225
pubmed: 32530381
Neuron. 2019 Mar 20;101(6):1109-1116.e5
pubmed: 30765166
Brain Stimul. 2022 Sep-Oct;15(5):1236-1245
pubmed: 36067978
Physiol Res. 2011;60(Suppl 1):S101-6
pubmed: 21777020
Brain Stimul. 2022 Nov-Dec;15(6):1348-1350
pubmed: 36174921
Neuroimage. 2021 Feb 1;226:117541
pubmed: 33186721
Clin Neurophysiol. 2000 Jan;111(1):178-83
pubmed: 10656526
Elife. 2020 Nov 25;9:
pubmed: 33236981
Neuron. 2018 Jun 6;98(5):875-877
pubmed: 29879389
Proc Natl Acad Sci U S A. 2022 Nov 16;119(46):e2206828119
pubmed: 36343238
Curr Biol. 2017 Dec 4;27(23):R1258-R1262
pubmed: 29207262
Exp Brain Res. 2004 Jul;157(1):1-9
pubmed: 14968278
Hum Brain Mapp. 2018 May;39(5):1995-2006
pubmed: 29380485
J Neurosci. 2013 Nov 20;33(47):18481-91
pubmed: 24259571
Eur J Neurosci. 2007 Mar;25(6):1874-81
pubmed: 17408427
Neuron. 2018 Jun 6;98(5):1031-1041.e5
pubmed: 29804920
Elife. 2019 Feb 12;8:
pubmed: 30747105
Neuron. 2018 Jun 6;98(5):1020-1030.e4
pubmed: 29804919
Exp Brain Res. 2004 Sep;158(1):120-4
pubmed: 15024542
Neuroimage. 2019 Jan 15;185:300-312
pubmed: 30347282
Clin Neurophysiol. 2022 Aug;140:59-97
pubmed: 35738037
Sci Rep. 2016 Sep 23;6:34026
pubmed: 27658372
Brain Stimul. 2019 Jul - Aug;12(4):901-910
pubmed: 30880027
Ultrasound Med Biol. 2021 May;47(5):1356-1366
pubmed: 33622622
Brain Topogr. 2021 Nov;34(6):720-730
pubmed: 34490506
Sci Rep. 2021 Mar 17;11(1):6100
pubmed: 33731821
Proc Natl Acad Sci U S A. 2021 Feb 9;118(6):
pubmed: 33542098
J Biomed Opt. 2010 Mar-Apr;15(2):021314
pubmed: 20459236
Curr Biol. 2007 Mar 20;17(6):R196-9
pubmed: 17371754
Brain Stimul. 2021 Sep-Oct;14(5):1353-1355
pubmed: 34481096
PLoS One. 2013 Sep 05;8(9):e73813
pubmed: 24040080
Brain Stimul. 2020 Nov - Dec;13(6):1527-1534
pubmed: 32891872
Clin Neurophysiol. 2022 Mar;135:51-73
pubmed: 35033772
Cell Rep. 2022 Aug 16;40(7):111197
pubmed: 35977493

Auteurs

Benjamin R Kop (BR)

Donders Institute for Brain, Cognition, and Behaviour; Radboud University Nijmegen, Nijmegen, Netherlands.

Yazan Shamli Oghli (Y)

Krembil Research Institute, University Health Network; University of Toronto, Toronto, Canada.

Talyta C Grippe (TC)

Krembil Research Institute, University Health Network; University of Toronto, Toronto, Canada.

Tulika Nandi (T)

Neuroimaging Center; Johannes-Gutenberg University Medical Center Mainz, Mainz, Germany.

Judith Lefkes (J)

Donders Institute for Brain, Cognition, and Behaviour; Radboud University Nijmegen, Nijmegen, Netherlands.

Sjoerd W Meijer (SW)

Donders Institute for Brain, Cognition, and Behaviour; Radboud University Nijmegen, Nijmegen, Netherlands.

Soha Farboud (S)

Donders Institute for Brain, Cognition, and Behaviour; Radboud University Nijmegen, Nijmegen, Netherlands.

Marwan Engels (M)

Donders Institute for Brain, Cognition, and Behaviour; Radboud University Nijmegen, Nijmegen, Netherlands.

Michelle Hamani (M)

Krembil Research Institute, University Health Network; University of Toronto, Toronto, Canada.

Melissa Null (M)

Neuroimaging Center; Johannes-Gutenberg University Medical Center Mainz, Mainz, Germany.

Angela Radetz (A)

Neuroimaging Center; Johannes-Gutenberg University Medical Center Mainz, Mainz, Germany.

Umair Hassan (U)

Neuroimaging Center; Johannes-Gutenberg University Medical Center Mainz, Mainz, Germany.

Ghazaleh Darmani (G)

Krembil Research Institute, University Health Network; University of Toronto, Toronto, Canada.

Andrey Chetverikov (A)

Donders Institute for Brain, Cognition, and Behaviour; Radboud University Nijmegen, Nijmegen, Netherlands.
Department of Psychosocial Science, Faculty of Psychology, University of Bergen, Bergen, Norway.

Hanneke E M den Ouden (HEM)

Department of Psychosocial Science, Faculty of Psychology, University of Bergen, Bergen, Norway.

Til Ole Bergmann (TO)

Neuroimaging Center; Johannes-Gutenberg University Medical Center Mainz, Mainz, Germany.
Leibniz Institute for Resilience Research Mainz, Mainz, Germany.

Robert Chen (R)

Krembil Research Institute, University Health Network; University of Toronto, Toronto, Canada.

Lennart Verhagen (L)

Donders Institute for Brain, Cognition, and Behaviour; Radboud University Nijmegen, Nijmegen, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH